Global Apoptosis Assay Kit Market Size By Product (Kits, Reagents, Instruments), By Application (Drug Discovery and Development, Stem Cell Research), By Geographic Scope And Forecast

Apoptosis Assay Kit Market Size And Forecast

Apoptosis Assay Kit Market size was valued at USD 4.26 Billion in 2020 and is projected to reach USD 9.26 Billion by 2028, growing at a CAGR of 10.2% from 2021 to 2028.

The major factors attributing to the growth of the Apoptosis Assay Kit Market are the increasing incidence of infectious and chronic diseases such as autoimmune diseases, cancer, and others. The Global Apoptosis Assay Kit Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Apoptosis Assay Kit Market Definition

The cell death mechanism plays a key role in the onset and progression of various human chronic conditions, wherein cell-death assays have potential in designing strategies. These strategies are chiefly targeted toward modulating the apoptosis pathway for therapy development. In addition, wide acceptance of clinically useful cytoprotective and cytotoxic agents that can be used in the treatment of ischemic diseases, cancer, and neurodegenerative diseases has led to an increase in the adoption of High-Throughput Screening assays; thereby driving the demand for cell-death assays over the years.

Global c Kit Market Overview

The major factors attributing to the growth of the Apoptosis Assay Kit Market are the increasing incidence of infectious and chronic diseases such as autoimmune diseases, cancer, and others. The rise in the population suffering from chronic and autoimmune diseases is propelling the demand for market growth. And there are few more factors that are playing crucial roles in taking the Apoptosis Assay Kit Market to the next level, among them is ongoing developments related to apoptosis-modulating drugs that are expected to further propel the growth of the global apoptosis assay kit market. However, the rising demand for high-content diagnosis and clinical research for cancer, in particular, is indeed bolstering market growth during the forecasted period.

The mounting funds assigned for cancer research coupled with innovations on apoptosis assays drugs are the driving factors expanding the market. Additionally, increased cell-based research along with rising cases of infectious diseases is positively influencing the market. The ability of assay kits to detect nuclear changes coupled with the adoption of assay kits in multiple procedures like environmental monitoring, life science research is stimulating the market. It is also used in the screening of drug candidates, evaluating biopharmaceutical production processes and studying diseases. Owing to these features, assay kits are expected to hold a majority share of the market.

In terms of detection technology, cell imaging and microscopy are forecasted to witness notable growth owing to the increasing preference towards cell imaging and microscopy in drug discovery applications, basic research, and diagnostic laboratories. Drug discovery and development holds a vast share of the market. The rising prevalence and incidence of infectious and chronic diseases are driving the demand for drug discovery and development. The increasing research and development activities coupled with mounting government efforts taken to develop new treatments for multiple diseases are expanding the apoptosis synthesis kit market size.

Global Apoptosis Assay Kit Market: Segmentation Analysis

The Global Apoptosis Assay Kit Market Segmented On The Basis Of Product, Application, And Geography.

Apoptosis Assay Kit Market, By Product

• Kits
• Reagents
• Instruments
• Others
• Based on Product, the market is segmented into Kits, Reagents, Instruments, Others. A gradual increase in the adoption of apoptosis assays across drug design and manufacturing is expected to offer lucrative opportunities to product manufacturers. The need for enhancing the efficiency of these assays has led to a considerable increase in the pool of manufacturers; wherein focus has been majorly on expanding apoptosis assay product offerings in the form of kits, reagents, and instruments

Apoptosis Assay Kit Market, By Application

• Drug Discovery and Development
• Stem Cell Research
• Others

Based on Application, the market is bifurcated into Drug Discovery and Development, Stem Cell Research, Others. Emerging techniques are inclusive of single-molecule spectroscopy, electrochemical techniques, and microfluidic devices. Flow cytometry is expected to dominate the global market throughout the forecast period as it is considered to be a gold standard detection method, whereas fluorescent microscopy is anticipated to register the fastest growth rate.

Apoptosis Assay Kit Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on regional analysis, the Global Apoptosis Assay Kit Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The presence of substantial universities and CROs that are engaged in the apoptosis research studies are attributive to the estimated share of North America. However, with the increasing capabilities of European and Asian countries, growth is expected to be driven by the CROs working from developing economies of these regions.

Key Players

The "Global Apoptosis Assay Kit Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Abcom plc, Merck KGaA (Germany), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), GE Healthcare (US), Danaher Corporation (US), Becton, Dickinson and Company (US), Sartorius AG (Germany), Geno Technology (US), Gene Copoeia, Inc. (US), and Promega Corporation (US) . The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• Product Launches and Product Expansions
• In 2018, Thermo Fisher Scientific launched Multiskan Sky Microplate Spectrophotometer.
• In 2018, GE Healthcare Life Sciences opened a new production facility in Pasching, Austria. The newly built manufacturing site will help to strengthen product supply for biopharmaceutical companies in Europe.